We are international
Donate
TEXT SIZE   
back

ASCO 2012: Dr. Nooka - Survival outcomes of early autologous stem cell transplant (ASCT) followed by lenalidomide, bortezomib, and dexamethasone (RVD) maintenance in patients with high-risk multiple myeloma (MM)
Ajay Nooka, MD
Winship Cancer Center
Emory University
Atlanta, Georgia, USA
06.26.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles